Your browser doesn't support javascript.
loading
Neutralizing antibody levels associated with injectable and aerosolized Ad5-nCoV boosters and BA.2 infection.
Wang, Fuzhen; Huang, Baoying; Deng, Yao; Zhang, Shaobai; Liu, Xiaoqiang; Wang, Lei; Liu, Qianqian; Zhao, Li; Tang, Lin; Wang, Wenling; Wang, Xiaoqi; Ye, Fei; Hu, Weijun; Yang, Haitao; Wang, Siquan; Ren, Jiao; Liu, Xiaoyu; Wang, Cangning; Guan, Xuhua; Wang, Ruize; Zheng, Yan; Zhang, Xianfeng; Zheng, Hui; Wu, Dan; An, Zhijie; Xu, Wenbo; Rodewald, Lawrence E; Gao, George F; Yin, Zundong; Tan, Wenjie.
  • Wang F; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Huang B; National Health Commission (NHC) Key Laboratory of Biosafety, Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Deng Y; National Health Commission (NHC) Key Laboratory of Biosafety, Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Zhang S; Shaanxi Provincial Center for Disease Control and Prevention, Xi'an, China.
  • Liu X; Yunnan Provincial Center for Disease Control and Prevention, Kunming, China.
  • Wang L; Hubei Provincial Center for Disease Control and Prevention, Wuhan, China.
  • Liu Q; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Zhao L; National Health Commission (NHC) Key Laboratory of Biosafety, Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Tang L; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Wang W; National Health Commission (NHC) Key Laboratory of Biosafety, Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Wang X; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Ye F; National Health Commission (NHC) Key Laboratory of Biosafety, Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Hu W; Shaanxi Provincial Center for Disease Control and Prevention, Xi'an, China.
  • Yang H; Yunnan Provincial Center for Disease Control and Prevention, Kunming, China.
  • Wang S; Hubei Provincial Center for Disease Control and Prevention, Wuhan, China.
  • Ren J; National Health Commission (NHC) Key Laboratory of Biosafety, Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Liu X; Shaanxi Provincial Center for Disease Control and Prevention, Xi'an, China.
  • Wang C; Yunnan Provincial Center for Disease Control and Prevention, Kunming, China.
  • Guan X; Hubei Provincial Center for Disease Control and Prevention, Wuhan, China.
  • Wang R; Shaanxi Provincial Center for Disease Control and Prevention, Xi'an, China.
  • Zheng Y; Yunnan Provincial Center for Disease Control and Prevention, Kunming, China.
  • Zhang X; Hubei Provincial Center for Disease Control and Prevention, Wuhan, China.
  • Zheng H; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Wu D; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.
  • An Z; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Xu W; National Health Commission (NHC) Key Laboratory of Biosafety, Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Rodewald LE; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Gao GF; Chinese Center for Disease Control and Prevention, Beijing, China.
  • Yin Z; National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China. yinzd@chinacdc.cn.
  • Tan W; National Health Commission (NHC) Key Laboratory of Biosafety, Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China. tanwj@ivdc.chinacdc.cn.
BMC Med ; 21(1): 233, 2023 07 03.
Article en En | MEDLINE | ID: mdl-37400857
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article